While no difference in CD73 expression on CD8+ TEM and TEMRA cells was noted between healthy controls and DLBCL patients, the CD8+ TN subset in DLBCL patients showed lower CD73 expression than in healthy controls (Figure 2B). This evidence concerns the gene CD8A and diffuse large B-cell lymphoma.